Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Assessment and monitoring of inflammation in COPD and asthma

Poster Discussion
Chairs: R. Djukanovic (Southampton, UK), D. Dusser (Paris, France)

Download all media

Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma J. Chlumsky (Prague, Czech Republic)
Nocturnal asthma is associated with elevated exhaled nitric oxide and eosinophils in induced sputum S. A. Kharitonov, W. Mattos, M. Leckie, T. T. Hansel, P. J. Barnes (London, United Kingdom)
Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone M. L. Nieto, A. De Diego, M. Perpina, L. Compte, V. Macian (Valencia, Spain)
Serum ECP in comparison to sputum ECP measurements in symptomatic and asymptomatic subjects with asthma J. Hermanowicz-Salamon, H. Grubek-Jaworska, J. Wronska, W. Droszcz, R. Chazan (Warsaw, Poland)
Predictive value of sputum eosinophilia for the rapid decline of FEV1 after a three-day withdrawal of therapy in asthmatic subjects I. Conti, A. Carletti, L. Scuotri, M. Tonelli, M. L. Bartoli, B. Vagaggini, E. Bacci, P. L. Paggiaro (Pisa, Italy)
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment V. Kehagia, L. Andri, E. Sekara, C. Syrigos, M. Linardakis, E. Zervas, C. Marossis, N. Papageorgiou (Athens, Greece)
Effect of salmeterol in asthmatic patients with low sputum eosinophils E. Bacci, L. Scuotri, M. L. Bartoli, S. Carnevali, S. Cianchetti, F. L. Dente, A. Di Franco, D. Giannini, B. Vagaggini, I. Conti, P. L. Paggiaro (Pisa, Italy)
Low doses of inhaled fluticasone propionate induce sputum eosinophil apoptosis and inhibit IL-5 release in naive symptomatic asthmatics (FLIC19) A. M. Vignola, S. Carnevali, A. Foresi, M. Profita, L. Riccobono, A. Pelucchi, P. Di Blasi, P. L. Paggiaro (Palermo, Pisa, Sesto San Giovanni, Verona, Italy)
Does sputum eosinophil counts predict the response to inhaled corticosteroids in terms of methacholine bronchial responsiveness in steroid naive asthmatics? D. M. Nguyen Dang, D. D. Cataldo, J. Sele, P. Bartsch, R. E. Louis (Liege, Belgium)
Symptoms, induced sputum eosinophil percentages and treatment with salmeterol or fluticasone in mild asthmatics M. Tonelli, D. Giannini, A. Di Franco, S. Carnevali, M. L. Bartoli, S. Cianchetti, E. Bacci, F. L. Dente, L. Scuotri, B. Vagaggini, P. L. Paggiaro (Pisa, Italy)
The anti-inflammatory effect of budesonide 800 μg/day via Easyhaler® compared with the same dose of budesonide via Turbuhaler® in adult asthmatics P. Rytilä, K. M. Hämäläinen, P. Saarelainen, T. Haahtela (Helsinki, Kuopio, Finland)
The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients W. J. C. van Beurden, D. A. Harff, R. N. R. Dekhuijzen, P. Salden, J. P. H. M. Creemers, F. W. J. M. Smeenk (Eindhoven, Nijmegen, Leiden, The Netherlands)
Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study S. Lim, A. Jatakanon, R. Stirling, P. J. Barnes, K. F. Chung (London, United Kingdom)
Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema E. Lee, H. L. Lee, A. Brown, S. A. Kilfeather (Sunderland, United Kingdom)
Eosinophil apoptosis in induced sputum (IS) from patients with mild symptomatic asthma during treatment with Fluticasone propionate (FP) S. Dorini, A. Pelucchi, C. Leone, B. Mastropasqua, R. Guarnieri, A. Chetta, R. D'Ippolito, R. Testi, D. Olivieri, A. Foresi (Sesto S. Giovanni, Parma, Verona, Italy)
Leukotriene B₄ receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema E. Lee, J. Smith, S. A. Kilfeather (Sunderland, United Kingdom)
Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with chronic obstructive pulmonary disease (COPD): a double-blind placebo-controlled, parallel-group quantitative study of bronchial biopsies E. Gamble, I. D. Pavord, A. M. Vignola, C. Kroegel, F. Morell, T. T. Hansel, C. Compton, S. Troy, J. D. Edelson, O. Amit, T. Tat, K. F. Rabe, N. C. Barnes, P. K. Jeffery, On behalf of a Multi-Centre European Trial Group (Harlow, United Kingdom)
The effects of oral clarithromycin on airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD) - a double blind randomised controlled trial D. Banerjee, S. Hussain, O. Khair, D. Honeybourne (Birmingham, United Kingdom)
Effect of systemic steroid treatment on nasal nitric oxide level in patients with chronic rhinosinusitis. A pilot study I. Horvath, I. Polony, M. Godeny, M. Augusztinovics (Budapest, Hungary)